Teva sharpens ax, preps brutal cuts in R&D and across the group in face of crushing debt
The word out of Israel today is that Teva is prepping a round of brutal cuts, with plans to shutter an R&D center and lay …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
